Genmab A (GMAB) Goodwill (2024 - 2026)

Genmab A has reported Goodwill for 3 years, with the latest figure at $355.0 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill changed 0.0% year-over-year to $355.0 million; the trailing twelve-month figure through Mar 2026 stood at $355.0 million (changed 0.0% YoY), and the FY2025 full-year result was $355.0 million, changed 0.0% from the prior year.
• Goodwill for Q1 2026 stood at $355.0 million, roughly flat from $355.0 million in the prior quarter.
• The five-year high for Goodwill was $355.0 million in Q4 2024, with the low at $355.0 million in Q4 2024.
• Historically, Goodwill has averaged $355.0 million across 3 years, with a median of $355.0 million in 2024.
• The largest YoY upside for Goodwill was 0.0% in 2025 against a maximum downside of 0.0% in 2025.
• Genmab A's Goodwill stood at $355.0 million in 2024, then changed by 0.0% to $355.0 million in 2025, then changed by 0.0% to $355.0 million in 2026.
• The last three Goodwill figures came in at $355.0 million (Q1 2026), $355.0 million (Q4 2025), and $355.0 million (Q3 2025), per Business Quant data.